Development of PV Agreements and Safety Data Exchange Agreements

Clear and well-structured agreements are essential for effective pharmacovigilance (PV) collaboration. At MedWatch Consulting, we specialize in drafting, reviewing, and maintaining Pharmacovigilance Agreements (PVAs) and Safety Data Exchange Agreements (SDEAs) that meet global regulatory requirements and protect your organization’s interests.

We ensure that each agreement clearly defines roles, responsibilities, timelines, and data exchange processes between partners, enabling smooth communication and regulatory compliance. Our team has extensive experience supporting licensing deals, co-development projects, distributor partnerships, and global collaborations where PVAs and SDEAs are a cornerstone.

With our guidance, you can establish agreements that provide both compliance and transparency, ensuring that safety information is shared reliably and that patient protection remains the top priority.

Contact us